Editorial: Recent advances in diagnosis and treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Main Author: | Semra Çaglar Çetinkaya |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-11-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2023.1332962/full |
Similar Items
-
Birth Size in Neonates with Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
by: Helmuth G. Dörr, et al.
Published: (2019-03-01) -
Mineralocorticoid replacement during infancy for salt wasting congenital adrenal hyperplasia due to 21-hydroxylase deficiency
by: Larissa G. Gomes, et al.
Published: (2013-01-01) -
Update on the Swedish Newborn Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
by: Rolf H. Zetterström, et al.
Published: (2020-08-01) -
Genetic and clinical characteristics including occurrence of testicular adrenal rest tumors in Slovak and Slovenian patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
by: Robert Saho, et al.
Published: (2023-03-01) -
Management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in children and adolescents: review
by: Barra, Cristina Botelho, et al.
Published: (2022-08-01)